Mucocutaneous findings in pediatric patients with bone marrow transplantation [Kemik iligi transplantasyonu yapilan pediyatrik olgularda mukokutanöz bulgular]

Basit Öğe Kaydı
dc.contributor.authorAksoylar S.
dc.contributor.authorCeylan C.
dc.contributor.authorGünaydin A.
dc.contributor.authorErtam I.
dc.contributor.authorKantar M.
dc.contributor.authorTuna A.
dc.contributor.authorÇetingül N.
dc.contributor.authorKansoy S.
dc.date.accessioned2019-10-27T08:04:39Z
dc.date.available2019-10-27T08:04:39Z
dc.date.issued2017
dc.departmentEge Üniversitesien_US
dc.description.abstractBackground and Design: Bone marrow transplantation (BMT) is performed for many malign and non-malign diseases in pediatric patients. Cutaneous signs in transplant patients are usually encountered in the presence of underlying primary diseases or due to the intense conditioning regimens that include chemotherapy and radiotherapy protocols. In this study, it is aimed to define mucocutaneous changes in pediatric patients with BMT. Materials and Methods: A total of 44 patients, in whom BMT was planned between 2010 and 2011, were included in the study. Dermatological examinations were performed at the beginning of the study and were repeated once a week in the first month, once a month in the following 5 months; and once in every 3 months in the last 1.5 years of follow-up. Results: Forty-one patients were completed the study. The mean age of 41 patients was 9.24 years (range: 1-17 years). Of the subjects, 26 (64%) were male and 15 (36%) were female. Dermatological signs, in order of frequency, were mucositis (75.6%), xeroderma (70.7%), alopecia (46.3%), nail disorders (24.3%), inflammatory skin diseases (24.2%), aphthous stomatitis (22%), cutaneous hyperpigmentation (22%), graft versus host diseases (17.1%), infectious diseases (15.5%), and maculopapular rash (4.8%). Conclusion: Dermatological diseases can be frequently observed in BMT patients. Close monitoring of dermatological signs is important to minimize the complications of the treatment in this patient group. © Telif Hakki 2017 Deri ve Zührevi Hastaliklar Dernegi.en_US
dc.identifier.doi10.4274/turkderm.90093
dc.identifier.endpage11en_US
dc.identifier.issn1019214X
dc.identifier.issn1019-214Xen_US
dc.identifier.issue1en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage7en_US
dc.identifier.urihttps://doi.org/10.4274/turkderm.90093
dc.identifier.urihttps://hdl.handle.net/11454/25546
dc.identifier.volume51en_US
dc.indekslendigikaynakScopusen_US
dc.language.isotren_US
dc.publisherIstanbul Assoc. of Dermatology and Venerologyen_US
dc.relation.ispartofTurkderm Deri Hastaliklari ve Frengi Arsivien_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectBone marrow transplantationen_US
dc.subjectChilden_US
dc.subjectSkinen_US
dc.titleMucocutaneous findings in pediatric patients with bone marrow transplantation [Kemik iligi transplantasyonu yapilan pediyatrik olgularda mukokutanöz bulgular]en_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu